vs

Side-by-side financial comparison of INNOSPEC INC. (IOSP) and Pebblebrook Hotel Trust (PEB). Click either name above to swap in a different company.

INNOSPEC INC. is the larger business by last-quarter revenue ($455.6M vs $345.7M, roughly 1.3× Pebblebrook Hotel Trust). INNOSPEC INC. runs the higher net margin — 10.4% vs -5.3%, a 15.7% gap on every dollar of revenue. On growth, Pebblebrook Hotel Trust posted the faster year-over-year revenue change (7.9% vs -2.4%). Pebblebrook Hotel Trust produced more free cash flow last quarter ($114.5M vs $46.8M). Over the past eight quarters, INNOSPEC INC.'s revenue compounded faster (-4.6% CAGR vs -6.7%).

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

Pebblebrook Hotel Trust is a publicly traded real estate investment trust (REIT) that owns, manages, and invests in upscale, luxury, and boutique hotel properties primarily across major urban and leisure destinations in the United States. Its portfolio caters to both business and leisure travelers, focusing on high-demand markets to deliver long-term value for stakeholders.

IOSP vs PEB — Head-to-Head

Bigger by revenue
IOSP
IOSP
1.3× larger
IOSP
$455.6M
$345.7M
PEB
Growing faster (revenue YoY)
PEB
PEB
+10.3% gap
PEB
7.9%
-2.4%
IOSP
Higher net margin
IOSP
IOSP
15.7% more per $
IOSP
10.4%
-5.3%
PEB
More free cash flow
PEB
PEB
$67.7M more FCF
PEB
$114.5M
$46.8M
IOSP
Faster 2-yr revenue CAGR
IOSP
IOSP
Annualised
IOSP
-4.6%
-6.7%
PEB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IOSP
IOSP
PEB
PEB
Revenue
$455.6M
$345.7M
Net Profit
$47.4M
$-18.4M
Gross Margin
28.0%
Operating Margin
10.3%
2.3%
Net Margin
10.4%
-5.3%
Revenue YoY
-2.4%
7.9%
Net Profit YoY
167.3%
31.8%
EPS (diluted)
$1.90
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IOSP
IOSP
PEB
PEB
Q1 26
$345.7M
Q4 25
$455.6M
$349.0M
Q3 25
$441.9M
$398.7M
Q2 25
$439.7M
$407.5M
Q1 25
$440.8M
$320.3M
Q4 24
$466.8M
$337.6M
Q3 24
$443.4M
$404.5M
Q2 24
$435.0M
$397.1M
Net Profit
IOSP
IOSP
PEB
PEB
Q1 26
$-18.4M
Q4 25
$47.4M
$-17.9M
Q3 25
$12.9M
$-33.1M
Q2 25
$23.5M
$18.1M
Q1 25
$32.8M
$-32.9M
Q4 24
$-70.4M
$-50.5M
Q3 24
$33.4M
$43.7M
Q2 24
$31.2M
$30.9M
Gross Margin
IOSP
IOSP
PEB
PEB
Q1 26
Q4 25
28.0%
Q3 25
26.4%
Q2 25
28.0%
Q1 25
28.4%
Q4 24
29.2%
Q3 24
28.0%
Q2 24
29.2%
Operating Margin
IOSP
IOSP
PEB
PEB
Q1 26
2.3%
Q4 25
10.3%
2.5%
Q3 25
1.3%
-2.6%
Q2 25
7.8%
12.9%
Q1 25
9.6%
-2.3%
Q4 24
8.8%
-6.7%
Q3 24
10.3%
11.6%
Q2 24
9.4%
15.4%
Net Margin
IOSP
IOSP
PEB
PEB
Q1 26
-5.3%
Q4 25
10.4%
-5.1%
Q3 25
2.9%
-8.3%
Q2 25
5.3%
4.4%
Q1 25
7.4%
-10.3%
Q4 24
-15.1%
-15.0%
Q3 24
7.5%
10.8%
Q2 24
7.2%
7.8%
EPS (diluted)
IOSP
IOSP
PEB
PEB
Q1 26
$-0.26
Q4 25
$1.90
$-0.22
Q3 25
$0.52
$-0.37
Q2 25
$0.94
$0.06
Q1 25
$1.31
$-0.37
Q4 24
$-2.80
$-0.47
Q3 24
$1.33
$0.24
Q2 24
$1.24
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IOSP
IOSP
PEB
PEB
Cash + ST InvestmentsLiquidity on hand
$292.5M
$196.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$2.4B
Total Assets
$1.8B
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IOSP
IOSP
PEB
PEB
Q1 26
$196.2M
Q4 25
$292.5M
$184.2M
Q3 25
$270.8M
$223.2M
Q2 25
$266.6M
$256.1M
Q1 25
$299.8M
$208.1M
Q4 24
$289.2M
$206.7M
Q3 24
$303.8M
$134.0M
Q2 24
$240.2M
$101.7M
Total Debt
IOSP
IOSP
PEB
PEB
Q1 26
Q4 25
$2.1B
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Stockholders' Equity
IOSP
IOSP
PEB
PEB
Q1 26
$2.4B
Q4 25
$1.3B
$2.5B
Q3 25
$1.3B
$2.5B
Q2 25
$1.3B
$2.6B
Q1 25
$1.3B
$2.6B
Q4 24
$1.2B
$2.7B
Q3 24
$1.2B
$2.8B
Q2 24
$1.2B
$2.7B
Total Assets
IOSP
IOSP
PEB
PEB
Q1 26
$5.3B
Q4 25
$1.8B
$5.3B
Q3 25
$1.8B
$5.6B
Q2 25
$1.8B
$5.7B
Q1 25
$1.8B
$5.7B
Q4 24
$1.7B
$5.7B
Q3 24
$1.8B
$5.7B
Q2 24
$1.7B
$5.7B
Debt / Equity
IOSP
IOSP
PEB
PEB
Q1 26
Q4 25
0.86×
Q3 25
0.89×
Q2 25
0.85×
Q1 25
0.85×
Q4 24
0.83×
Q3 24
0.80×
Q2 24
0.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IOSP
IOSP
PEB
PEB
Operating Cash FlowLast quarter
$61.4M
Free Cash FlowOCF − Capex
$46.8M
$114.5M
FCF MarginFCF / Revenue
10.3%
33.1%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IOSP
IOSP
PEB
PEB
Q1 26
Q4 25
$61.4M
$249.7M
Q3 25
$39.3M
$77.6M
Q2 25
$9.3M
$90.5M
Q1 25
$28.3M
$50.3M
Q4 24
$25.7M
$275.0M
Q3 24
$73.5M
$76.1M
Q2 24
$4.7M
$83.7M
Free Cash Flow
IOSP
IOSP
PEB
PEB
Q1 26
$114.5M
Q4 25
$46.8M
$152.3M
Q3 25
$25.0M
$6.8M
Q2 25
$-3.7M
Q1 25
$19.9M
Q4 24
$13.6M
$146.3M
Q3 24
$65.8M
$-24.8M
Q2 24
$-6.2M
FCF Margin
IOSP
IOSP
PEB
PEB
Q1 26
33.1%
Q4 25
10.3%
43.6%
Q3 25
5.7%
1.7%
Q2 25
-0.8%
Q1 25
4.5%
Q4 24
2.9%
43.3%
Q3 24
14.8%
-6.1%
Q2 24
-1.4%
Capex Intensity
IOSP
IOSP
PEB
PEB
Q1 26
Q4 25
3.2%
27.9%
Q3 25
3.2%
17.7%
Q2 25
3.0%
Q1 25
1.9%
Q4 24
2.6%
38.1%
Q3 24
1.7%
24.9%
Q2 24
2.5%
Cash Conversion
IOSP
IOSP
PEB
PEB
Q1 26
Q4 25
1.30×
Q3 25
3.05×
Q2 25
0.40×
5.01×
Q1 25
0.86×
Q4 24
Q3 24
2.20×
1.74×
Q2 24
0.15×
2.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

PEB
PEB

Room$214.5M62%
Food and beverage$91.1M26%
Other$40.0M12%

Related Comparisons